Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography, and the nuclear imaging modalities of PET and SPECT.

Bristol Myers Squibb will pay $350M-plus to add prostate cancer imaging agent
Subsidiary RayzeBio has inked a definitive deal to license the worldwide rights for the drug from Philochem, a Swiss biotechnology firm.
FDA issues recall of Philips interventional imaging system due to safety risks
A communication error within the system can reportedly cause loss of imaging functionality mid-procedure.
FDA-cleared software increases throughput for flurpiridaz back-to-back rest-stress imaging
The new F-18 flurpiridaz radiotracer is expected to help drive cardiac PET growth, but it requires waiting between rest and stress scans. Software from MultiFunctional Imaging can help care teams combat that problem.
A new payer tactic: Using AI to curtail routine radiology claims, after imaging is already delivered
“Unlike [prior authorization], this model does not delay patient care and does not hold members liable to pay for unneeded exams,” writes radiologist Mark Hiatt, MD, MBA.
'Promising' new PET agent for brain metastases put on FDA's Fast Track
Clinical trial results thus far have been promising, representing a significant step forward for the hundreds of thousands of patients affected by brain metastases.

Private equity-backed Solis Mammography inks ‘groundbreaking’ partnership with HCA Healthcare

MountainStar is teaming with the Addison, Texas-based women's imaging group to fine-tune its radiology strategy across Utah.

Richard Heller, MD, RSNA Board member, associate chief medical officer for health policy and communications, and national director of pediatric radiology at Radiology Partners, explains some insurance companies are trying to take advantage of the No Surprises Billing Act by telling radiology practices they need to accept lower rates to remain part of the providers in-network.

Radiologists urged to report insurance companies forcing lower reimbursements due to No Surprises Act

Some payers are taking advantage of the NSA by forcing practices to accept lower rates to remain in-network, says Rad Partners' Richard Heller, MD.

Jamie Bourque, MD, medical director of the nuclear cardiology and stress laboratory, and medical director of the echocardiography lab, at the University of Virginia, discusses a new multimodality consensus statement for imaging cardiac amyloidosis. This area has rapidly expanded over the past couple years now that there are drugs to treat the condition.

New ASNC quality metrics will support standardization of imaging for cardiac amyloidosis

Interest in cardiac amyloidosis has been on the rise in recent years. Jamie Bourque, MD, talked to Cardiovascular Business about an upcoming consensus statement focused on using cardiac imaging to evaluate patients for signs of this serious condition.

Digital biomarker tool for rapidly identifying lung fibrosis cleared by FDA

The AI-guided technology can diagnose the disease via medical images without the need for an invasive procedure.

RSNA announces course on deploying AI in emergency care

The six-module offering will focus on leveraging artificial intelligence to speed up scans and improve report reading in urgent care scenarios.

ASRT granting $400K in scholarships to radiology students

Founded in 1984, the American Society of Radiologic Technologists Foundation is hoping to raise big money for the next generation of imaging professionals.

Rob deKemp, PhD, FASNC, University of Ottawa, Canada, explains new nuclear cardiac imaging dose lowering techniques for PET and SPECT.

How to achieve much lower radiation doses in cardiac nuclear imaging

The radiation doses associated with CT have decreased significantly, leaving nuclear cardiology as the modality with the highest doses in all of cardiac imaging. Rob deKemp, PhD, talked to us about some of the many ways imagers can work to address this issue.

Lab receives $30M funding to illuminate lung and ovarian cancers

On Target Laboratories will use the funding to expand the market reach of its molecular imaging agent.

Medical Imaging

Bristol Myers Squibb will pay $350M-plus to add prostate cancer imaging agent

FDA issues recall of Philips interventional imaging system due to safety risks

FDA-cleared software increases throughput for flurpiridaz back-to-back rest-stress imaging

A new payer tactic: Using AI to curtail routine radiology claims, after imaging is already delivered

'Promising' new PET agent for brain metastases put on FDA's Fast Track